Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
2.29 SEK | +0.88% | +2.23% | -38.11% |
04-26 | Q-Linea AB Receives FDA 510(k) Clearance for the ASTar® System | CI |
03-13 | Q-linea AB Presents Strong ASTar Results At AMCLI | CI |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
Quarterly revenue - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
-38.11% | 24.47M | |
-42.26% | 2.85B | |
+20.51% | 1.94B | |
-1.13% | 1.68B | |
+27.00% | 1.26B | |
-14.07% | 1.03B | |
-20.60% | 938M | |
+0.88% | 783M | |
-24.35% | 628M | |
+8.73% | 535M |
- Stock Market
- Equities
- QLINEA Stock
- News Q-linea AB
- Q-linea to Develop Diagnostic Product Podler Via Separate Subsidiary